The author is in the Departments of Medicine, Pathology and Laboratory Medicine, and Pediatrics, Division of Pulmonary and Critical Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California 90095-1786, USA. rstrieter@mednet.ucla.edu
Fresh approaches are needed for antiangiogenesis therapies that target blood vessel growth in tumors. Knocking down multiple regulators of angiogenesis might provide a way forward (pages 992−997).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
